Evidence map›Paper›PMID 31334235›Full record

ArticleFrontiers in medicine2019

Building a Professional Identity and an Academic Career Track in Translational Medicine.

Sabine J van Dijk, Andrea A Domenighetti, Natalia Gomez-Ospina, Patricia Hunter, Caroline A Lindemans, Veerle Melotte, Annemarie M C van Rossum, Norman D Rosenblum

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Advancing translational science education.Clinical and translational science · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 4 countries.

Sabine J van DijkDepartment of Pharmacology, University of California, Davis, Davis, CA, United States.
Andrea A DomenighettiThe Shirley Ryan AbilityLab, Chicago, IL, United States.
Natalia Gomez-OspinaDivision of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Patricia HunterUCL Great Ormond Street Institute of Child Health, University College of London, London, United Kingdom.
Caroline A LindemansUniversity Medical Center Utrecht, Wilhelmina Children's Hospital (WKZ), Utrecht University, Utrecht, Netherlands.
Veerle MelotteDepartment of Pathology, Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, Netherlands.
Annemarie M C van RossumDivision of Infectious Diseases and Immunology, Department of Pediatrics, Erasmus MC University Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands.
Norman D RosenblumLaboratory Medicine and Pathobiology, Departments of Paediatrics, Physiology, University of Toronto, Toronto, ON, Canada.
Erasmus MC - Sophia Children’s Hospital · NLGreat Ormond Street Hospital · GBMaastricht University · NLNorthwestern University · USStanford University · USUniversity of California, Davis · USUniversity of Toronto · CAWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomedical scientists aim to contribute to further understanding of disease pathogenesis and to develop new diagnostic and therapeutic tools that relieve disease burden. Yet the majority of biomedical scientists do not develop their academic career or professional identity as "translational scientists," and are not actively involved in the continuum from scientific concept to development of new strategies that change medical practice. The collaborative nature of translational medicine and the lengthy process of bringing innovative findings from bench to bedside conflict with established pathways of building a career in academia. This collaborative approach also poses a problem for evaluating individual contributions and progress. The traditional evaluation of scientific success measured by the impact and number of publications and grants scientists achieve is inadequate when the product is a team effort that may take decades to complete. Further, where scientists are trained to be independent thinkers and to establish unique scientific niches, translational medicine depends on combining individual insights and strengths for the greater good. Training programs that are specifically geared to prepare scientists for a career in translational medicine are not widespread. In addition, the legal, regulatory, scientific and clinical infrastructure and support required for translational research is often underdeveloped in academic institutions and funding organizations, further discouraging the development and success of translational scientists in the academic setting. In this perspective we discuss challenges and potential solutions that could allow for physicians, physician scientists and basic scientists to develop a professional identity and a fruitful career in translational medicine.

Indexed as

basic scientistbiomedical sciencescareer trackphysician scientisttranslational medicinetranslational scientist

Identifiers

PMID31334235
PMCPMC6618343
OpenAlexW2949133208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.